3,4-Methylenedioxymethamphetamine (MDMA, or 'ecstasy') and associated hypoglycemia [10]

American Journal of Emergency Medicine

Volumn 15, Issue 2, 1997, Pages 218-

  Montgomery, H ^a   Myerson, S ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DANTROLENE; DIAZEPAM;

ADULT; BLOOD CLOTTING DISORDER; CASE REPORT; CLINICAL FEATURE; EMERGENCY TREATMENT; FEMALE; GRAND MAL EPILEPSY; HUMAN; HYPOGLYCEMIA; LETTER; PRIORITY JOURNAL; RHABDOMYOLYSIS; SUBSTANCE ABUSE; TACHYPNEA;

EID: 0030975569     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(97)90117-0     Document Type: Letter

References (5)

1. JA Henry KJ Jeffreys S Dawling Toxicity and deaths from 3,4-methylenedioxymethamphetamine (ecstasy) Lancet 340 1992 384 387
2. SI Khakoo CJ Coles JS Armstrong Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymethamphetamine (ecstasy) usage J Clin Gastroenterol 20 1995 244 247
3. NY Walton Systemic effects of generalised convulsive status epilepticus Epilepsia 34 suppl 1 1993 S54 S58
4. JJA Heffron Malignant hyperthermia: Biochemical aspects of the acute episode Br J Anaesth 60 1988 274 278
5. T Bichel JL Canivet P Danas M Lamy Malignant hyperthermia and severe hypoglycaemia after re-exposure to halothane Acta Anaesth Belg 45 1994 23 27